| Trial Identifier: | 3475-051 |
| Sponsor: | MSD |
| Start Date: | March 2015 |
| Primary Completion Date: | February 2028 |
| Study Completion Date: | February 2028 |
| Condition: | Skin Cancer; Hodgkin's lymphoma; Cancer - Other; Lymphoma |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary-English |
| Country | Location |
|---|---|
| Brazil | Sao Paulo, Brazil |
| France | Paris, France |
| Germany | München, Germany |
| Israel | Hod Hasharon, Israel |
| Italy | Rome, Italy |
| Korea, Republic of | Seoul, Korea, Republic of, 4130 |
| Netherlands | Haarlem, Netherlands |
| Portugal | Paco D'arcos, Portugal |
| Sweden | Stockholm, Sweden |
| United Kingdom | London, United Kingdom |
| United States, CO | Aurora, CO, United States, 80045 |
| United States, IL | Chicago, IL, United States, 60637 |
| United States, MA | Boston, MA, United States, 02445 |
| United States, ND | Fargo, ND, United States, 58102 |
| United States, NY | New York, NY, United States, 10032 |
| United States, SD | Sioux Falls, SD, United States, 57117 |
| United States, TX | Dallas, TX, United States, 75235 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2026 Pharma Intelligence UK Limited (Citeline), a Norstella company